Hypoxia-Inducible Factor-1α C1772T Polymorphism and Cancer Risk: A Meta-Analysis Including 18,334 Subjects

REFERENCES

• Dang CV, Semenza GL. Oncogenic alterations of metabolism. Trends Biochem Sci 1999;24:68–72.
   PubMed Web of Science ®Google Scholar
• Folkman J, Merler E, Abernathy C, Williams G. Isolation of a tumor factor responsible for angiogenesis. J Exp Med 1971;133:275–288.
   PubMed Web of Science ®Google Scholar
• Semenza GL. HIF-1 and human disease: one highly involved factor. Genes Dev 2000;14:1983–1991.
   PubMed Web of Science ®Google Scholar
• Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basichelix–loop–helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 1995;92:5510–5514.
   PubMed Web of Science ®Google Scholar
• Tanimoto K, Yoshiga K, Eguchi H, Kaneyasu M, Ukon K, Kumazaki T, Oue N, Yasui W, Imai K, Nakachi K, Poellinger L, Nishiyama M. Hypoxia-inducible factor-1alpha polymorphisms associated with enhanced transactivation capacity, implying clinical significance. Carcinogenesis 2003;24:1779–1783.
   PubMed Web of Science ®Google Scholar
• Zhong H, Semenza GL, Simons JW, De Marzo AM. Upregulation of hypoxia-inducible factor 1alpha is an early event in prostate carcinogenesis. Cancer Detect Prev 2004;28:88–93.
   PubMedGoogle Scholar
• Semenza GL. Regulation of mammalian O2 homeostasis by hypoxiainducible factor 1. Annu Rev Cell Dev Biol 1999;15: 551–578.
   PubMed Web of Science ®Google Scholar
• Ryan HE, Poloni M, McNulty W. Hypoxia-inducible factor-1 is a positive factor in solid tumor growth. Cancer Res 2000;60: 4010–4015.
   PubMed Web of Science ®Google Scholar
• Konac E, Onen HI, Metindir J, Alp E, Biri AA, Ekmekci A. An investigation of relationships between hypoxia- inducible factor-1 alpha gene polymorphisms and ovarian, cervical and endometrial cancers. Cancer Detec Prev 2007;31:102–109.
   PubMedGoogle Scholar
• Chai D, Chen YL, Zheng A, Liu YY, Chu YX, Han L. Relationship between polymorphism of hypoxia inducible factor-1alpha and cervical cancer in Han population in Sichuan Province of China. Sichuan Da Xue Xue Bao Yi Xue Ban 2010;41:674–677.
   PubMedGoogle Scholar
• Kim YH, Park IA, Park WY, Kim JW, Kim SC, Park NH, Song YS, Kang SB. Hypoxia-inducible factor 1α polymorphisms and early-stage cervical cancer. Int J Gynecol Cancer 2011;21:2–7.
   PubMed Web of Science ®Google Scholar
• Kuwai T, Kitadai Y, Tanaka S, Kuroda T, Ochiumi T, Matsumura S, Oue N, Yasui W, Kaneyasu M, Tanimoto K, Nishiyama M, Chayama K. Single nucleotide polymorphismin the hypoxia-inducible factor-1alpha gene in colorectal carcinoma. Oncol Rep. 2004;12:1033–1037.
   PubMed Web of Science ®Google Scholar
• Fransén K, Fenech M, Fredrikson M, Dabrosin C, Söderkvist P. Association between ulcerative growth and hypoxia inducible factor-1alpha polymorphisms in colorectal cancer patients. Mol Carcinog 2006;45:833–840.
   PubMed Web of Science ®Google Scholar
• Knechtel G, Szkandera J, Stotz M, Hofmann G, Langsenlehner U, Krippl P, Samonigg H, Renner W, Langner C, Dehchamani D, Gerger A. Single nucleotide polymorphisms in the hypoxia-inducible factor-1 gene and colorectal cancer risk. Mol Carcinog 2010;49:805–809.
   PubMed Web of Science ®Google Scholar
• Lee JY, Choi JY, Lee KM, Park SK, Han SH, Noh DY, Ahn SH, Kim DH, Hong YC, Ha E, Yoo KY, Ambrosone CB, Kang D. Rare variant of hypoxia-inducible factor-1alpha (HIF-1α) and breast cancer risk in Korean women. Clin Chim Acta 2008;389: 167–170.
   PubMed Web of Science ®Google Scholar
• Apaydin I, Konac E, Onen HI, Akbaba M, Tekin E, Ekmekci A. Single nucleotide polymorphisms in the hypoxia-inducible factor-1alpha (HIF-1alpha) gene in human sporadic breast cancer. Arch Med Res 2008;39:338–345.
   PubMed Web of Science ®Google Scholar
• Kim HO, Jo YH, Lee J, Lee SS, Yoon KS. The C1772T genetic polymorphism in human HIF-1alpha gene associates with expression of HIF-1alpha protein in breast cancer. Oncology Reports 2008;20:1181–1187.
   PubMed Web of Science ®Google Scholar
• Chau CH, Permenter MG, Steinberg SM, Retter AS, Dahut WL, Price DK, Figg WD. Polymorphism in the hypoxia-inducible factor 1alpha gene may confer susceptibility to androgen-independent prostate cancer. Cancer Biol Ther 2005;4: 1222–1225.
   PubMed Web of Science ®Google Scholar
• Orr-Urtreger A, Bar-Shira A, Matzkin H, Mabjeesh NJ. The homozygous P582S mutation in the oxygen-dependent degradation domain of HIF-1 alpha is associated with increased risk for prostate cancer. Prostate 2007;67:8–13.
   PubMed Web of Science ®Google Scholar
• Li H, Bubley GJ, Balk SP, Gaziano JM, Pollak M, Stampfer MJ, Ma J. Hypoxia-inducible factor-1alpha (HIF-1alpha) gene polymorphisms, circulating insulin-like growth factor binding protein (IGFBP)-3 levels and prostate cancer. Prostate 2007;67:1354–1361.
   PubMed Web of Science ®Google Scholar
• Jacobs EJ, Hsing AW, Bain EB, Stevens VL, Wang Y, Chen J, Chanock SJ, Zheng SL, Xu J, Thun MJ, Calle EE, Rodriguez C. Polymorphisms in angiogenesis-related genes and prostate cancer. Cancer Epidemiol Biomarkers Prev 2008;17:972–977.
   PubMed Web of Science ®Google Scholar
• Foley R, Marignol L, Thomas AZ, Cullen IM, Perry AS, Tewari P, O'Grady A, Kay E, Dunne B, Loftus B, Watson WR, Fitzpatrick JM, Woodson K, Lehman T, Hollywood D, Lynch TH, Lawler M. The HIF-1alpha C1772T polymorphism may be associated with susceptibility to clinically localised prostate cancer but not with elevated expression of hypoxic biomarkers. Cancer Biol Ther 2009;8:118–124.
   PubMed Web of Science ®Google Scholar
• Chen MK, Chiou HL, Su SC, Chung TT, Tseng HC, Tsai HT, Yang SF. The association between hypoxia inducible factor-1alpha gene polymorphisms and increased susceptibility to oral cancer. Oral Oncol 2009;45:e222–e226.
   PubMed Web of Science ®Google Scholar
• Muñoz-Guerra MF, Fernández-Contreras ME, Moreno AL, Martín ID, Herráez B, Gamallo C. Polymorphisms in the hypoxia inducible factor 1-alpha and the impact on the prognosis of early stages of oral cancer. Ann Surg Oncol 2009;16:2351–2358.
   PubMed Web of Science ®Google Scholar
• Shieh TM, Chang KW, Tu HF, Shih YH, Ko SY, Chen YC, Liu CJ. Association between the polymorphisms in exon 12 of hypoxia-inducible factor-1alpha and the clinicopathological features of oral squamous cell carcinoma. Oral Oncol 2010;46:e47–e53.
   PubMed Web of Science ®Google Scholar
• Clifford SC, Astuti D, Hooper L, Maxwell PH, Ratcliffe PJ, Maher ER. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma. Oncogene 2001;20:5067–5074.
   PubMed Web of Science ®Google Scholar
• Ollerenshaw M, Page T, Hammonds J, Demaine A. Polymorphisms in the hypoxia inducible factor-1alpha gene (HIF1α) are associated with the renal cell carcinoma phenotype. Cancer Genet Cytogenet 2004;153:122–126.
   PubMed Web of Science ®Google Scholar
• Morris MR, Hughes DJ, Tian YM, Ricketts CJ, Lau KW, Gentle D, Shuib S, Serrano-Fernandez P, Lubinski J, Wiesener MS, Pugh CW, Latif F, Ratcliffe PJ, Maher ER. Mutation analysis of hypoxia-inducible factors HIF1A and HIF2A in renal cell carcinoma. Anticancer Res 2009;29:4337–4343.
   PubMed Web of Science ®Google Scholar
• Ling TS, Shi RH, Zhang GX, Zhu H, Yu LZ, Ding XF. Common single nucleotide polymorphism of hypoxia-inducible factor-1alpha and its impact on the clinicopathological features of esophageal squamous cell carcinoma. Chin J Dig Dis 2005;6:155–158.
   PubMedGoogle Scholar
• Konac E, Dogan I, Onen HI, Yurdakul AS, Ozturk C, Varol A, Ekmecki A. Geneticvariations in the hypoxia-inducible factor-1alpha gene and lung cancer. Exp Biol Med (Maywood). 2009;234:1109–1116.
   PubMed Web of Science ®Google Scholar
• Li K, Zhang Y, Dan Z, Wang Y, Ren ZC. Association of the hypoxia inducible factor-1alpha gene polymorphisms with gastric cancerin Tibetans. Biochem Genet 2009;47:625–634.
   PubMed Web of Science ®Google Scholar
• Hsiao PC, Chen MK, Su SC, Ueng KC, Chen YC, Hsieh YH, Liu YF, Tsai HT, Yang SF. Hypoxia inducible factor-1alpha gene polymorphism G1790A and its interaction with tobacco and alcohol consumptions increase susceptibility to hepatocellular carcinoma. J Surg Oncol 2010;102:163–169.
   PubMed Web of Science ®Google Scholar
• Wang X, Liu Y, Ren H, Yuan Z, Li S, Sheng J, Zhao T, Chen Y, Liu F, Wang F, Huang H, Hao J. Polymorphisms in the hypoxia-inducible factor-1α gene confer susceptibility to pancreatic cancer. Cancer Biol Ther 2011;12:383–387.
   PubMed Web of Science ®Google Scholar
• Xu G, Wang M, Xie W, Bai X. Hypoxia-inducible factor-1 alpha C1772T gene polymorphism and glioma risk: a hospital-based case–control study from China. Genet Test Mol Biomarkers 2011;15:461–464.
   PubMed Web of Science ®Google Scholar
• Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Part 4: Heterogeneity. Introduction to meta analysis. UK: Wiley Publishing Group, 2009, 450.
   Google Scholar
• Cochran WG. The combination of estimates from different experiments. Biometrics 1954;10:101–129.
   Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177–188.
   PubMed Web of Science ®Google Scholar
• Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719–48.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M. Bias in metaanalysis detected by a simple, graphical test. BMJ 1997;315:629–634.
   PubMed Web of Science ®Google Scholar
• Tanaka H, Yasuda Y, Musha T, Ueda K, Nakamura Y. Hypoxia correlates with angiogenesis in cervical cancers. Int J Clin Oncol. 2005;10:35–39.
   PubMedGoogle Scholar
• Tang X, Zhang Q, Nishitani J, Brown J, Shi S, Le AD. Overexpression of human papillomavirus type 16 oncoproteins enhances hypoxia-inducible factor 1 alpha protein accumulation and vascular endothelial growth factor expression in human cervical carcinoma cells. Clin Cancer Res. 2007;13:2568–2576.
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407:249–257.
   PubMed Web of Science ®Google Scholar
• Fu XS, Choi E, Bubley GJ, Balk SP. Identification of hypoxiainducible factor-1alpha (HIF-1alpha) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation. Prostate 2005;63:215–221.
   PubMed Web of Science ®Google Scholar
• Kimbro KS, Simons JW. Hypoxia-inducible factor-1 in human breast and prostate cancer. Endocr Relat Cancer 2006;13:739–749.
   PubMed Web of Science ®Google Scholar
• Huss WJ, Hanrahan CF, Barrios RJ, Simons JW, Greenberg NM. Angiogenesis and prostate cancer: Identification of a molecular progression switch. Cancer Res 2001;61:2736–2743.
   PubMed Web of Science ®Google Scholar
• Zhong H, Semenza GL, Simons JW, De Marzo AM. Upregulation of hypoxia-inducible factor 1alpha is an early event in prostate carcinogenesis. Cancer Detect Prev 2004;28:88–93.
   PubMedGoogle Scholar
• Percy MJ, Mooney SM, McMullin MF, Flores A, Lappin TR, Lee FS. A common polymorphism in the oxygen-dependent degradation (ODD) domain of hypoxia inducible factor-1alpha (HIF-1alpha) does not impair Pro-564 hydroxylation. Mol Cancer 2003;2:31.
   PubMedGoogle Scholar
• Wang J, Stockton DW, Ittmann M. The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression. Clin Cancer Res 2004;10: 6169–6178.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, Minder C. Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med 2006;354:333–342.
   PubMed Web of Science ®Google Scholar
• Pietsch EC, Humbey O, Murphy ME. Polymorphisms in the p53 pathway. Oncogene 2006;25:1602–1611.
   PubMed Web of Science ®Google Scholar